Key result
Elevated homocysteine linked to ~4% higher odds of reduced LVEF in pediatric myocarditis.
Why the study?
The relationship between homocysteine and ejection fraction has been shown in diseases like coronary artery disease, but remains unclear in pediatric myocarditis.
Are elevated homocysteine levels associated with reduced ejection fraction in pediatric patients with myocarditis?
Cross-Sectional (n=164)
No
Are elevated homocysteine levels associated with reduced ejection fraction in pediatric patients with myocarditis?
Elevated plasma homocysteine levels are associated with an increased risk of reduced ejection fraction (<55%) in pediatric patients with myocarditis, particularly in males and overweight individuals.
Answers are grounded in this paper and cite their sources.
May help stratify risk of reduced EF in pediatric myocarditis; leaves open causality and needs prospective confirmation.
Background The relationship between homocysteine (HCY) and ejection fraction (EF) has been demonstrated in diseases such as coronary artery disease, but the relationship between HCY and EF in pediatric patients with myocarditis remains unclear. The aim of this study was to investigate the relationship between HCY and EF in pediatric patients with myocarditis. Methods This single-center cross-sectional study included 164 pediatric myocarditis patients aged 1–18 years, including 104 males and 60 females, at Anzhen Hospital (2023–2024) in Beijing. Patient demographic characteristics were collected, and blood tests were performed to assess HCY, routine blood tests, and markers of myocardial damage. EF was measured using 3.0T cardiac magnetic resonance (CMR), and patients were grouped using EF < 55% as the cutoff value. Statistical analyses were performed using t-tests, Binary logistic regression and Restrict cubic spline (RCS), and subgroup analyses [age, sex, body mass index (BMI)]. Results Of the 164 patients, 31% ( n = 51) had EF values < 55%. High HCY concentration demonstrated a statistically positive relationship with the risk of occurrence of EF < 55% (OR = 1.033, P = 0.034). Subgroup analysis showed a stronger correlation in men (OR = 1.045, P = 0.016) and in those with a BMI ≥ 24 kg/m 2 (OR = 1.083, P = 0.010). The RCS showed a non-significant trend of increasing EF < 55% ( P > 0.05). Conclusion The findings suggest that elevated HCY levels are a risk factor for EF < 55% in pediatric patients with myocarditis, especially in males and overweight individuals.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cross-sectional in pediatric myocarditis (n=164). Elevated homocysteine levels vs. Lower/normal homocysteine levels was evaluated on Risk of reduced ejection fraction (EF < 55%) assessed by cardiac magnetic resonance (CMR) (OR 1.038, 95% CI 1.003-1.074, p=0.033). Elevated homocysteine levels were associated with a 3.8% increased odds of reduced ejection fraction in pediatric myocarditis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: